PGNY — Progyny Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Progyny, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	345	501	787	1,089	1,167
Cost of Revenue
Gross Profit	70.1	112	167	239	253
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses	337	468	764	1,026	1,100
Operating Profit	8.35	32.3	23.3	62.2	67.5
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	8.68	32.4	24.4	70.7	83.2
Provision for Income Taxes
Net Income After Taxes	46.5	65.8	30.4	62	54.3
Net Income Before Extraordinary Items
Net Income	46.5	65.8	30.4	62	54.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	46.5	65.8	30.4	62	54.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.536	0.655	0.304	0.616	0.579